top of page

UK Construction Media: IPG CEO on ditching diesel without disrupting build programs

IPG CEO Toby Gill explores the challenges facing construction companies in the bid to decarbonise on-site power generation, and examines the benefits of fuel-agnostic generators as a scalable, futureproof solution.


Beyond the challenges of procuring cost-effective alternative generators, replacing diesel generators with HVO or hydrogen powered solutions brings with it operational risk. Companies wishing to scale these single-fuel solutions across their business are having to weigh the increased risk of delivery disruptions and power outages that emerging supply chains for alternative fuels currently present.

A construction worker in hi vis and hard hat guides a diesel generator as it is lowered onto a construction site.

Switching today from diesel to green hydrogen, for example, is to go from a solution with an almost-guaranteed fuel supply and energy security to one with less reliable availability. But every time lack of supply pushes a company or site manager to purchase a new diesel generator, the transition to renewable fuels is delayed by the lifetime of this asset. In the case of the diesel generator this is seven years – a delay the construction industry cannot afford.


Fuel flexible generators can provide the solution, facilitating the removal of diesel from sites without compromising the energy security currently offered by traditional fossil fuels.


This technology ensures resilience to changes in regulation and fuel market dynamics, enabling companies to make tangible strides today in decarbonising daily operations and moving away from a reliance on fossil fuels.


Why should contractors limit themselves to a single fuel, if they don’t have to?


 

The above is an excerpt from Toby’s article “If hydrogen is the answer, what is the question?” published on UK Construction Media. Read the full article here.

IMG_2444.JPG

Get in touch

To learn more about IPG’s breakthrough technology, join our latest funding round or find out how to get involved with our future commercial trials, contact us:

bottom of page